Showing results (4931-4940 of 5,597) with videos related to
Sort By:
Pageof 560
Journal of Cancer|August 9, 2018
The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4Liu Yang, Yang Guo, Xin Liu, et al.Journal of Cancer|August 9, 2018
Clinic-pathologic Features and Prognostic Analysis of Thyroid Cancer in the Older Adult: A SEER Based StudyLi-Ye Shi, Jiang Liu, Lu-Jiao Yu, et al.Journal of Cancer|August 9, 2018
Involvement of Aryl Hydrocarbon Receptor and Aryl Hydrocarbon Receptor Repressor in Helicobacter Pylori-related Gastric PathogenesisRenfei Zhu, Cheng Gao, Liuhua Wang, et al.Journal of Cancer|May 4, 2018
Long-Term Outcome of Oxaliplatin and Capecitabine (XELOX) Concomitant with Neoadjuvant Radiotherapy and Extended to the Resting Period in High Risk Locally Advanced Rectal CancerJinghua Tang, Xiaojun Wu, Yanfang Bai, et al.Journal of Cancer|May 4, 2018
Secretory Clusterin Mediates Oxaliplatin Resistance via the Gadd45a/PI3K/Akt Signaling Pathway in Hepatocellular CarcinomaXin Wang, Fang Zou, Jingtao Zhong, et al.Journal of Cancer|May 4, 2018
International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary ConferenceNaoto T Ueno, Jose Rodrigo Espinosa Fernandez, Massimo Cristofanilli, et al.Journal of Cancer|May 4, 2018
Cancer Stem Cells are Regulated by STAT3 Signalling in Wilms TumourYanmei Liu, Xuexiang Gao, Shuo Wang, et al.Journal of Cancer|May 4, 2018
Shared liver-like transcriptional characteristics in liver metastases and corresponding primary colorectal tumorsJun Cheng, Xuekun Song, Lu Ao, et al.Journal of Cancer|August 21, 2018
Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracilYukihisa Tamaki, Yoko Hieda, Masanobu Nakajima, et al.Journal of Cancer|August 21, 2018
The Efficacy and Safety of Apatinib Treatment for Patients with Unresectable or Relapsed Liver Cancer: a retrospective studyLiu Zhen, Chen Jiali, Fang Yong, et al.Pageof 560